Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper

Br J Dermatol. 2023 Feb 10;188(2):195-197. doi: 10.1093/bjd/ljac050.
No abstract available

Publication types

  • Clinical Trial, Phase III

MeSH terms

  • Alopecia Areata* / drug therapy
  • Azetidines* / therapeutic use
  • Humans
  • Sulfonamides

Substances

  • baricitinib
  • Azetidines
  • Sulfonamides

Supplementary concepts

  • Diffuse alopecia